Objective: To investigate the relationship of parathyroid hormone (PTH) with dietary calcium and changes in body composition. Design: Cross-sectional and 1-year longitudinal trial. Subjects: Normal-weight young women (age: 18-31), 155 subjects analyzed at baseline, and data for 41 subjects analyzed prospectively between baseline and 12 months. Measurements: Levels of fasting serum calcium and PTH, intakes of calcium (3-day diet records), and total body weight and body composition (dual energy X-ray absorptiometry). Results: Baseline dietary calcium, regardless of whether unadjusted or adjusted for energy intake, did not predict baseline levels of fasting serum PTH. Change in dietary calcium also did not predict change in serum PTH. However, log PTH was significantly correlated with body fat mass (R ¼ 0.27), but not lean mass at baseline (n ¼ 155), independent of serum calcium (corrected R ¼ 0.25). Further, 12-month changes (n ¼ 41) in log PTH positively predicted the 12-month change in body weight (R ¼ 0.32) and body fat (R ¼ 0.32), but not lean mass even when controlled for age or change in serum calcium. Conclusion: Fasting serum PTH was associated with increased fat mass, in both cross-sectional and prospective analysis. Thus, serum PTH may play a role in the regulation of body fat mass in young women.
Introduction
In recent years, obesity has become a global epidemic. It is a risk factor for chronic diseases such as heart disease, cancer, stroke, and diabetes, and weight loss can reduce risk. 1 Previously, increased levels of fasting parathyroid hormone (PTH) have been hypothesized to influence increased levels of body fat mass. 2 Studies show that serum PTH levels are higher in obese than in nonobese young adults 3, 4 and decline with weight loss. [5] [6] [7] In addition, hyperparathyroid postmenopausal women have a greater fat mass with a more android pattern of fat distribution compared to age-matched controls. 8 Serum PTH has also been proposed to mediate the putative effect of dietary calcium on changes in body composition. A variety of studies demonstrate that higher intakes of calcium or dairy products, the predominant dietary source of calcium in the US, are associated with weight loss, with some showing specificity to fat mass loss. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] For example, we conducted a secondary analysis of data collected in our laboratory during a 2-year exercise intervention trial in 54 young, healthy women. 16 Results indicated that calcium intake, adjusted for calories, was negatively associated with changes in body weight and fat mass in women whose energy intakes were at or below the overall group mean of 1876 kcal/day. 16 While many studies support a relationship between dietary calcium or dairy products and weight or body fat, the mechanisms have yet to be clearly established. Dietary calcium regulation of serum PTH is one of the proposed mechanisms.
It is well established that dietary calcium intake leads to an acute increase in serum calcium, which in turn leads to a suppression in serum PTH. 22 Previously, we demonstrated that higher dietary calcium or dairy product intake is associated with a reduction in fat mass over 2-years 16 ( Figure 1 , pathway A). The current study utilized archived serum samples from this previous study 16 to explore the association of dietary calcium to fasting PTH levels ( Figure 1 , pathway B) and fasting PTH levels to body composition ( Figure 1 , pathway C) in normal weight young women by both cross-sectional and prospective analyses.
Methods

Subjects
An association between increased dietary calcium intake and reduced body fat was established. An intervention study was designed to examine the effect of exercise on bone measures, providing an opportunity to prospectively study the relationship of dietary calcium to serum PTH, and serum PTH to body composition. Caucasian women (18-31 years old) were recruited through direct mail, radio announcements, and flyers. 22 Eligible subjects who completed baseline testing as described below were randomized into either the exercise group (n ¼ 94) or the nonexercise group (n ¼ 61, total ¼ 155), and these baseline data were used for cross-sectional analyses. In all, 41 subjects, who had both body composition data and serum results for calcium and PTH at baseline and 12 months, were analyzed prospectively. As a result of rolling enrollment, data were collected over a 5-year period during all seasons of the year. Reasons for withdrawal or exclusion were time constraints (31%), pregnancy (11%), moving (4%), medical (4%), personal (2%), end of funding period (9%), and incomplete data (12%). The study protocol was approved by Purdue University's Institutional Review Board and all participants signed informed consent forms.
Exclusion criteria
Exclusion criteria included the following: chronic intake of medication that would interfere with calcium metabolism, irregular menses (less than 9 in the previous year), a history of diabetes, greater than 20% overweight or 15% underweight, and participation in more than 2 h/week of exercise in the year prior to entry into the study.
Exercise protocol
The recreational sports complex at Purdue University includes a super circuit room where the resistance exercise portion (Universal Weight Machines, Cedar Rapids, IA, USA) of the protocol was performed. The super circuit consisted of two sets of eight upper body and eight lower body weight stations with a cycle ergometer located between each station. The overall exercise protocol for this study was as follows: (1) three sessions/week of the super circuit described above; and (2) 60 min/week of jumping rope in any combination of minutes. All participants were oriented to the super circuit by one of two research assistants. During the orientation they were instructed on proper use of each weight station, which included how to log each visit on standard forms that were kept at the site. Details on the implementation of the protocol have been described previously. 21 Compliance was assessed at 6-month intervals by changes in lean mass (kg, dual-energy absorptiometer (DXA), Lunar Corp., version 1.2, Madison, WI, USA), changes in strength (lb), and on-site records of the weight-lifting sessions maintained by participants. In addition, subjects kept daily records which included physical activity and minutes jumping rope. Average compliance to the protocol over 12 months, assessed by self-reported records, was 47.273.6% of the prescribed three times/week weight-lifting sessions and 40.375.1% of the prescribed 60 min/week jumping rope for a combined compliance of 43.173.9% to the prescribed protocol. In addition, strength (one repetition maximum assessed at each station with improvement from baseline summed across stations) increased from baseline to 12 months by 368731 lb. Lean mass also increased in the exercisers (2.970.5%) compared to no change (0.270.4%) in the nonexercisers.
Dietary calcium assessment
Dietary intake was assessed by a 3-day diet record, including intake of supplements, at baseline, 6 and 12 months. All dietary records collected over 12 months were analyzed by Parathyroid hormone and body composition CW Gunther et al the same trained dietitian using Computrition (Chatsworth, CA, USA). Based on both repeated measures and paired t-test analysis, there were no significant differences in nutrient intake between baseline and 6 or 12 months. There were also no significant differences in nutrient intake at any of the time points between the exercisers and nonexercisers. Thus, in addition to both baseline and 12-month measures, an overall mean for calcium and energy was calculated from baseline, 6, and 12 month intakes for each subject.
Blood collection and serum analyses Blood samples were taken at baseline and 12 months, and quantified for calcium and PTH between 1991-1994. Serum calcium was measured on the Roche Cobas Mira using Arsenazo III dye to form the complex, and EDTA to separate the bound from unbound calcium. A two-site immunoradiometric assay (Allegro Intact PTH Immunoassay, Nichols Institute) was utilized to assess the biologically intact 84-amino-acid chain of PTH. All samples of serum calcium or PTH were assessed in a batch analysis.
Body composition assessment
Weight was measured with a calibrated balance beam scale and height was measured with a wall-mounted stadiometer with subjects wearing light clothing and no shoes. Fat and lean mass (kg) and percent fat were assessed with a DXA (Lunar Corp., Madison, WI, USA) at baseline and 12 months. DXA data collection and analysis were supervised by one technician throughout the 5-year study period. Review of the uniformity of data collection and analysis procedures among the trained DXA technicians was completed on a regular basis throughout the study period and adjustments made as necessary to insure consistency across technicians (Clinical Nutrition Research Center, Indiana University Medical Center). To insure quality control throughout the period of study, a spine phantom was assessed daily to determine if any drift in the machine occurred. This was followed by a daily calibration block. If the results of the spine phantom varied by 2% or greater, corrective measures were taken.
Statistical analyses
Means, standard deviations, and correlations were computed for all variables, and data are expressed as mean7s.d. Univariate analyses were used to determine skewness. PTH distribution was skewed; therefore, the natural log of PTH was used in all statistical analyses. For the prospective analysis, body composition variables and PTH were expressed as change from baseline to 12 months, and regression methods were used to relate changes in body composition measures to changes in log PTH. There were no significant differences between those subjects whose data were analyzed for baseline only (n ¼ 114) and those used in prospective analyses. Most analyses were conducted with and without controlling for age, since age correlated with weight (R ¼ 0.27, P ¼ 0.0008), fat mass (R ¼ 0.21, P ¼ 0.009), lean mass (R ¼ 0.23, P ¼ 0.005), and change in log PTH at 12 months (R ¼ 0.30, P ¼ 0.05). Results of all significant relationships were similar when analyses were controlled for season (October-March, lower sun exposure; April-September, higher sun exposure) or year of recruitment. Analyses were conducted with SAS software (Version 8.1), and results were considered significant at Pp0.05.
Results
The relationships of dietary calcium with both serum calcium and log PTH were explored in cross-sectional analyses at baseline and in prospective analyses employing 12-month changes. These results are presented separately below.
Baseline
The baseline physical characteristics of the subjects are shown in Table 1 . Since serum calcium levels are a primary negative regulator of PTH levels, baseline serum calcium was negatively associated with log PTH (R ¼ À0.29, P ¼ 0.0003) as would be expected. Baseline dietary calcium intake (calcium (mg) or calcium/energy (mg/kcal)) did not predict baseline serum calcium or log PTH (R-values ranged from À0.11 to 0.03).
The relationships between baseline serum calcium or log PTH and body composition measures are shown in Table 2 . Serum calcium negatively correlated with body weight and fat mass, but not lean mass, when results were controlled for age, and lean mass when results were controlled for log PTH. In contrast, log PTH positively correlated with body weight and body fat, but not lean mass, even when analyses were controlled for age. However, the relationship between log PTH and body weight became insignificant when controlled for serum calcium. These results suggest that serum calcium, independent of log PTH, is negatively associated with body weight and lean mass, but not fat mass, and log PTH, Parathyroid hormone and body composition CW Gunther et al independent of serum calcium, is positively associated with body fat mass, but not body weight and lean mass.
Prospective analyses
The 12-month change in calcium intake, whether unadjusted or adjusted for energy intake, did not correlate with 12-month changes in serum calcium or log PTH (R-values ranged from À0.20 to 0.16). However, there was a trend toward a significant correlation (R ¼ À0.28, P ¼ 0.09) between the mean 12-month intake in diet calcium/energy ratio and 12-month change in log PTH. The 12-month change in serum calcium did not correlate with the 12-month change in lean mass when controlled for age or change in log PTH. In contrast, the 12-month change in log PTH positively correlated with 12-month changes in body weight and body fat mass, but not lean mass (Table 3) , even when analyses were controlled for age or change in serum calcium. Finally, a regression equation was developed to predict 12-month changes in body fat mass by 12-month changes in log PTH ((change in fat mass ¼ (0.2270.48) þ (change log PTH*(2.2471.04)); P ¼ 0.04, R 2 ¼ 0.11). Inclusion of age, change in serum calcium, oral contraceptive use, exercise group assignment, or dietary calcium measures did not contribute further to the above model.
Discussion
Previous results from our laboratory showed that higher dietary calcium intakes, when corrected for calories, are associated with decreased fat mass over 2-years in 54 healthy women, ages 18-31 years old. 16 In the current study, changes in PTH levels were associated with increased fat mass in the same cohort of young women. To our knowledge, this is the first prospective report of a relationship between changes within normal ranges of PTH and changes in fat mass in normal weight young women.
The results of the current study are consistent with previous evidence showing that serum PTH levels are higher in obese than in nonobese young adults. 3, 4 In addition, Kamycheva et al. 23 recently demonstrated that serum levels of PTH are positively correlated with BMI in a large crosssectional study (n ¼ 7954). In this study, the relative risk of obesity was greater for those in the highest quartile of serum PTH values, independent of gender. In addition, PTH was positively correlated with BMI and body fat mass in study of 302 nonobese and obese mixed race adults 24 and in morbidly obese patients. 25 Several studies show that PTH declines with weight loss, either diet-induced 5 or following gastric surgery for obesity. 6 Similar to these reports, our results support a positive relationship between PTH and body fat mass in a crosssectional analyses, and we also demonstrate that a change in PTH correlates to a change in body fat mass in a prospective analysis. However, in contrast, some studies suggest a rise in PTH with diet-induced weight loss. 26 Dietary calcium loads are known to cause acute reductions in PTH levels. 27 We showed in our previous study that higher dietary calcium intakes were associated with decreases in body fat mass. 16 In the current study, utilizing the same cohort, decreased PTH levels were associated with decreases in body fat mass. Although there were no significant relationships between dietary calcium and serum PTH at any time points, a trend was observed between 12-month dietary calcium and change in serum PTH. Several hypotheses may explain this paradox. First, the variability of the dietary calcium and PTH levels may prevent detection of a significant difference as compared with the more accurate DXA assessment of body composition. Greater variability results, in part, from the fact that dietary calcium intake is difficult to accurately assess. 28 Second, although acute dietary calcium intake suppresses PTH levels, they recover within 8 h to baseline levels after the calcium dose. 27 It is not clear how multiple doses of calcium over a 12-h period followed by a 12-h fast affect serum PTH levels assessed after the fasting period. Thus, fasting PTH may not reflect overall levels and, under these conditions, the relationship between fasting PTH and dietary calcium may be difficult to detect. In addition to this, the relationships of dietary calcium and PTH to body fat mass may be coincidental, or mediated by independent or synergistic regulators. There are several strengths and limitations of this study to be considered. The strengths of the study include methods utilized for data collection and the confirmation of the results in both cross-sectional and prospective analysis. On the other hand, the parent study was not designed to test the hypothesis proposed in the current study. Second, the small sample size for the prospective analysis may not provide sufficient power to identify all significant relationships. Finally, the collection of data occurred over 5-years. However, numerous quality control measures were employed to minimize data collection variability during this longitudinal study. In addition, the potential impact of seasonal changes and time of entry into the study was addressed statistically and found to have no impact.
In order to assess the biological impact of changes in PTH to changes in body fat mass, the regression equation described in the Results section was applied employing the results from this study sample. The mean 12-month change of this cohort in log PTH is À0.0270.46, with the minimum and maximum changes being À0.96 and 0.98, respectively. A decrease or increase in log PTH of 70.85, both within the range of the current cohort, were selected for this analysis. A decrease in log PTH (À0.85) predicted a loss of À1.68 kg of body fat over 12 months ((0.2270.48)7À0.85 (change in log PTH)*(2.2471.04) ¼ À1.68 kg), compared to an increase in log PTH (0.85), which predicted a 2.12-kg increase in body fat.
Thus, the results of this study support a relationship between changes in fasting serum PTH and changes in body fat in normal-weight humans. To our knowledge, a prospective relationship of changes in serum PTH to changes in body fat has not been reported previously in normal-weight young women. Further studies are needed to clarify the critical regulators of fasting serum PTH, including vitamin D, as well as to examine if: (1) change in PTH within the normal range directly causes change in body fat accumulation; 2 and/ or (2) the change in PTH levels are a consequence of body fat changes.
